
Opinion|Videos|April 4, 2025
Payer and Reimbursement Considerations for Bispecific Therapies
Experts discuss how payer and reimbursement considerations affect access to bispecific therapies in different practice settings.
Advertisement
Episodes in this series

Video content above is prompted by the following:
How do payer and reimbursement considerations affect access to bispecific therapies in different practice settings?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
AbbVie Joins Trump Drug Pricing Effort, Pledges $100B in US R&D Investment
2
OpenAI for Healthcare Aims to Streamline Clinical Workflows, Reduce Administrative Burden
3
Managed Care Cast News Roundup: January 13, 2026
4
How EHRs Help Identify Diabetes Risk in Families of Adults With Prediabetes
5





























































